US equities
|
SPCX
$171.09
▲+0.00%
NVDA
$238.90
▲+0.00%
MU
$1,063.96
▲+0.00%
AMD
$631.75
▲+0.00%
TSLA
$378.73
▲+0.00%
SNDK
$1,704.16
▲+0.00%
SKHY
$195.02
▲+0.00%
SDEV
$3.94
▲+0.00%
SPCX
$171.09
▲+0.00%
NVDA
$238.90
▲+0.00%
MU
$1,063.96
▲+0.00%
AMD
$631.75
▲+0.00%
TSLA
$378.73
▲+0.00%
SNDK
$1,704.16
▲+0.00%
SKHY
$195.02
▲+0.00%
SDEV
$3.94
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Sionna Therapeutics, Inc. - Common Stock
(NQ:
SION
)
4.850
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sionna Therapeutics, Inc. - Common Stock
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
April 22, 2025
Via
Benzinga
Alcoa Posts Weak Revenue, Joins QXO And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
April 17, 2025
Via
Benzinga
Why Liberty Energy Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
↗
April 17, 2025
Via
Benzinga
Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
March 20, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
AI Mobility Provider, Steel Veteran Made Trading Debuts
↗
March 02, 2025
AI Mobility provider Webus International, steel industry veteran Luda Technology, Chinese ad services provider LZ Technology, and Singapore-based med-tech Basel Medical all made their public debuts...
Via
Talk Markets
Topics
Artificial Intelligence
Stocks / Equities
Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference
February 24, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 10, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics, Titan America Made Public Debut
↗
February 09, 2025
Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial...
Via
Talk Markets
Topics
Stocks / Equities
< Previous
1
2
3
Next >
